Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Agilon Health's Enterprise Value is $1,792 Mil.
Agilon Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-366 Mil. Therefore, Agilon Health's EV-to-EBIT ratio for today is -4.90.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Agilon Health's Enterprise Value is $1,792 Mil.
Agilon Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-337 Mil. Therefore, Agilon Health's EV-to-EBITDA ratio for today is -5.32.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Agilon Health's Enterprise Value is $1,792 Mil.
Agilon Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $5,820 Mil. Therefore, Agilon Health's EV-to-Revenue ratio for today is 0.31.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Agilon Health's Enterprise Value is $1,792 Mil.
Agilon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-85 Mil. Therefore, Agilon Health's EV-to-FCF ratio for today is -20.98.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Agilon Health (NYSE:AGL) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Agilon Health's current Enterprise Value is $1,792 Mil.
Agilon Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-366 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Agilon Health's current Enterprise Value is $1,792 Mil.
Agilon Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-337 Mil.
Agilon Health's current Enterprise Value is $1,792 Mil.
Agilon Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,820 Mil.
Agilon Health's current Enterprise Value is $1,792 Mil.
Agilon Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-50 Mil.
Agilon Health's current Enterprise Value is $1,792 Mil.
Agilon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health Enterprise Value Related Terms
Agilon Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Agilon Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AGL vs AVAH, HCSG, SNDA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Agilon Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Agilon Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Agilon Health's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health (AGL) has a Enterprise Value of $1,792 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Agilon Health and its competitors.
Is Agilon Health's Enterprise Value too high?
Agilon Health's current Enterprise Value is $1,792 Mil. Overall, Agilon Health has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Enterprise Value compare to AVAH and HCSG?
Agilon Health's Enterprise Value of $1,792 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Agilon Health and its competitors. Agilon Health's current Enterprise Value is $1,792 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.48, compared to a current price of $119.25 — trading 26.2% above its estimated fair value. The current Enterprise Value is $1,792 Mil. Agilon Health's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Agilon Health (AGL), the current Enterprise Value is $1,792 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $119.25 is trading 26.2% above its estimated GF Value™ of $94.48.
GuruFocus considers Agilon Health to be Modestly Overvalued.
Key valuation signals for AGL:
Enterprise Value: $1,792 Mil
GF Value™: $94.48 vs. price of $119.25 (26.2% above fair value)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
73GF Score
Get the complete analysis for AGL
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
